SCHEMBL24257851

SCHEMBL24257851

CCNC(=O)c1ncc(C#Cc2ccccc2)c(C)c1O

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 16/20 0.49
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
EGLN3 Q9H6Z9 2/20 0.40
PIN1 Q13526 1/20 0.40
GRM5 P41594 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257490 0.89 EGLN1 (0.63) EGLN1EGLN3
SCHEMBL24257632 0.87 EGLN1 (0.56) EGLN1EGLN3
SCHEMBL24257805 0.76 EGLN1 (0.47) EGLN1
SCHEMBL24257465 0.75 EGLN1 (0.66) EGLN1EGLN3
SCHEMBL24257816 0.75 EGLN1 (0.47) EGLN1PIN1
SCHEMBL18736097 0.73 EGLN1 (0.78) EGLN1EGLN3
SCHEMBL1658418 0.69 GRM5 (0.55) EGLN1HSP90AA1HSP90AB1PIN1GRM5
SCHEMBL24257742 0.68 GABRA1 (0.41) EGLN1EGLN3
SCHEMBL13310735 0.67 PIN1 (0.43) PIN1
SCHEMBL18736103 0.67 EGLN1 (0.61) EGLN1EGLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022036188-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed